Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib in Metastatic Colorectal Cancer
NCT00052507Phase 2Completed
- Sponsor
- University Health Network
- Start
- Jan 2003
- Primary completion
- Aug 2005
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in colorectal cancer (CRC), sponsored by University Health Network. Started Jan 2003; status: completed.
02
Drugs
bortezomib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00052507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00052507.